2018 Q1 Form 10-Q Financial Statement
#000114420418025078 Filed on May 03, 2018
Income Statement
| Concept | 2018 Q1 | 2017 Q1 |
|---|---|---|
| Revenue | $4.023M | $2.712M |
| YoY Change | 48.35% | |
| Cost Of Revenue | $1.839M | $1.459M |
| YoY Change | 26.06% | 49.81% |
| Gross Profit | $2.184M | $1.253M |
| YoY Change | 74.33% | |
| Gross Profit Margin | 54.29% | 46.2% |
| Selling, General & Admin | $3.653M | $2.773M |
| YoY Change | 31.73% | -9.38% |
| % of Gross Profit | 167.23% | 221.31% |
| Research & Development | $329.7K | $249.8K |
| YoY Change | 31.97% | 72.93% |
| % of Gross Profit | 15.1% | 19.94% |
| Depreciation & Amortization | $187.8K | $131.6K |
| YoY Change | 42.78% | 80.44% |
| % of Gross Profit | 8.6% | 10.5% |
| Operating Expenses | $3.983M | $3.023M |
| YoY Change | 31.75% | 1992.23% |
| Operating Profit | -$1.798M | -$1.769M |
| YoY Change | 1.66% | |
| Interest Expense | $0.00 | $15.67K |
| YoY Change | -100.0% | -119.58% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $15.77K | $0.00 |
| YoY Change | ||
| Pretax Income | -$2.682M | -$1.785M |
| YoY Change | 50.25% | -34.13% |
| Income Tax | $813.00 | $4.231K |
| % Of Pretax Income | ||
| Net Earnings | -$2.683M | -$1.789M |
| YoY Change | 49.96% | |
| Net Earnings / Revenue | -66.68% | -65.97% |
| Basic Earnings Per Share | ||
| Diluted Earnings Per Share | -$100.1K | -$101.7K |
| COMMON SHARES | ||
| Basic Shares Outstanding | 27.34M shares | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2018 Q1 | 2017 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $19.00M | $14.50M |
| YoY Change | 31.03% | 417.86% |
| Cash & Equivalents | $18.99M | $14.53M |
| Short-Term Investments | ||
| Other Short-Term Assets | $500.0K | $300.0K |
| YoY Change | 66.67% | 50.0% |
| Inventory | $121.9K | $70.96K |
| Prepaid Expenses | ||
| Receivables | $2.400M | $1.468M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $22.04M | $16.39M |
| YoY Change | 34.47% | 296.73% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $2.572M | $2.100M |
| YoY Change | 22.49% | 59.12% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $400.0K | $400.0K |
| YoY Change | 0.0% | 0.0% |
| Total Long-Term Assets | $3.042M | $2.507M |
| YoY Change | 21.33% | 48.19% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $22.04M | $16.39M |
| Total Long-Term Assets | $3.042M | $2.507M |
| Total Assets | $25.08M | $18.90M |
| YoY Change | 32.72% | 224.53% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $1.300M | $1.700M |
| YoY Change | -23.53% | 30.77% |
| Accrued Expenses | $1.100M | $400.0K |
| YoY Change | 175.0% | -20.0% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $600.0K | |
| YoY Change | 50.0% | |
| Total Short-Term Liabilities | $2.400M | $2.634M |
| YoY Change | -8.89% | 21.19% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $0.00 |
| YoY Change | -100.0% | |
| Other Long-Term Liabilities | $200.0K | $200.0K |
| YoY Change | 0.0% | |
| Total Long-Term Liabilities | $200.0K | $200.0K |
| YoY Change | 0.0% | -66.67% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $2.400M | $2.634M |
| Total Long-Term Liabilities | $200.0K | $200.0K |
| Total Liabilities | $2.632M | $2.834M |
| YoY Change | -7.12% | 3.87% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$134.1M | |
| YoY Change | ||
| Common Stock | $156.6M | $141.4M |
| YoY Change | 10.75% | 21.63% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $22.45M | $16.07M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $25.08M | $18.90M |
| YoY Change | 32.72% | 224.55% |
Cashflow Statement
| Concept | 2018 Q1 | 2017 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$2.683M | -$1.789M |
| YoY Change | 49.96% | |
| Depreciation, Depletion And Amortization | $187.8K | $131.6K |
| YoY Change | 42.78% | 80.44% |
| Cash From Operating Activities | -$1.064M | -$829.9K |
| YoY Change | 28.16% | -57.87% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $269.5K | $631.1K |
| YoY Change | -57.29% | -253.92% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | ||
| YoY Change | ||
| Cash From Investing Activities | -$284.9K | -$641.3K |
| YoY Change | -55.57% | 56.41% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $0.00 | $11.57M |
| YoY Change | -100.0% | |
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 5.300M | $11.48M |
| YoY Change | -53.83% | -14449.42% |
| NET CHANGE | ||
| Cash From Operating Activities | -1.064M | -$829.9K |
| Cash From Investing Activities | -284.9K | -$641.3K |
| Cash From Financing Activities | 5.300M | $11.48M |
| Net Change In Cash | 3.952M | $10.01M |
| YoY Change | -60.51% | -506.84% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$1.064M | -$829.9K |
| Capital Expenditures | $269.5K | $631.1K |
| Free Cash Flow | -$1.333M | -$1.461M |
| YoY Change | -8.75% | -6.35% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2185143 | USD |
| CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
2377345 | USD |
| CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-131432883 | USD |
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
17886766 | USD |
| CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
20264111 | USD |
| CY2018Q1 | us-gaap |
Inventory Net
InventoryNet
|
121926 | USD |
| CY2018Q1 | us-gaap |
Assets Current
AssetsCurrent
|
22043286 | USD |
| CY2018Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2572298 | USD |
| CY2018Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
105996 | USD |
| CY2018Q1 | us-gaap |
Deposits Assets
DepositsAssets
|
363403 | USD |
| CY2018Q1 | us-gaap |
Assets
Assets
|
25084983 | USD |
| CY2018Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1345047 | USD |
| CY2018Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1074532 | USD |
| CY2018Q1 | us-gaap |
Liabilities
Liabilities
|
2631706 | USD |
| CY2018Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
27593 | USD |
| CY2018Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
156541327 | USD |
| CY2018Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-134115643 | USD |
| CY2018Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
22453277 | USD |
| CY2018Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
25084983 | USD |
| CY2018Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
541462 | USD |
| CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
516427 | USD |
| CY2018Q1 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
189054 | USD |
| CY2017Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
192202 | USD |
| CY2018Q1 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
4023189 | USD |
| CY2017Q1 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
2712234 | USD |
| CY2018Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1838826 | USD |
| CY2017Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1458737 | USD |
| CY2018Q1 | us-gaap |
Gross Profit
GrossProfit
|
2184363 | USD |
| CY2017Q1 | us-gaap |
Gross Profit
GrossProfit
|
1253497 | USD |
| CY2018Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
3982668 | USD |
| CY2017Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
3022810 | USD |
| CY2018Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1798305 | USD |
| CY2017Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1769313 | USD |
| CY2018Q1 | us-gaap |
Interest Expense
InterestExpense
|
0 | USD |
| CY2017Q1 | us-gaap |
Interest Expense
InterestExpense
|
15667 | USD |
| CY2018Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
15768 | USD |
| CY2017Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
0 | USD |
| CY2018Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-2681947 | USD |
| CY2017Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-1784980 | USD |
| CY2018Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
813 | USD |
| CY2017Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
4231 | USD |
| CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2682760 | USD |
| CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1789211 | USD |
| CY2017Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1703032 | USD |
| CY2017Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1069935 | USD |
| CY2018Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
329730 | USD |
| CY2017Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
249843 | USD |
| CY2018Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
899410 | USD |
| CY2017Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | USD |
| CY2018Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
187834 | USD |
| CY2017Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
131551 | USD |
| CY2018Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
0 | USD |
| CY2017Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
6130 | USD |
| CY2018Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1049510 | USD |
| CY2017Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
770442 | USD |
| CY2018Q1 | us-gaap |
Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
|
-20585 | USD |
| CY2017Q1 | us-gaap |
Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
|
-17238 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Long Term Receivables Current
IncreaseDecreaseInLongTermReceivablesCurrent
|
760428 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Long Term Receivables Current
IncreaseDecreaseInLongTermReceivablesCurrent
|
272370 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
7130 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-18539 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
105343 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
329514 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
149018 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-5413 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
0 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-1843 | USD |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1063653 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-829923 | USD |
| CY2018Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
269543 | USD |
| CY2017Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
631082 | USD |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-284893 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-641281 | USD |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
5300351 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
11479535 | USD |
| CY2018Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
3951805 | USD |
| CY2017Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
10008331 | USD |
| CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4524529 | USD |
| CY2017Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
14532860 | USD |
| CY2017Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
10199 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
34500 | USD |
| CY2018Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
| CY2018Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2018Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2500000 | shares |
| CY2018Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2018Q1 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
9136777 | shares |
| CY2017Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
70000 | USD |
| CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2500000 | shares |
| CY2017Q1 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
0 | USD |
| CY2018Q1 | us-gaap |
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
0 | USD |
| CY2017Q1 | us-gaap |
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
165990 | USD |
| CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
| CY2018Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
27593118 | shares |
| CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
25701924 | shares |
| CY2018Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
27593118 | shares |
| CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
25701924 | shares |
| CY2018Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
| CY2017Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
11571914 | USD |
| CY2018Q1 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
4641807 | USD |
| CY2017Q1 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
0 | USD |
| CY2018Q1 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
658544 | USD |
| CY2018Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><strong><i>Use of Estimates</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 24.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 24.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from estimated amounts. The Company’s significant estimates include the allowance for doubtful accounts, recoverability of long-lived assets, allowance for inventory obsolescence, deferred taxes and their accompanying valuations, and valuation of equity instruments. </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2018Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 24.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><strong><i>Concentrations of Credit Risk</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 24.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 24.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The Company maintains its cash accounts in financial institutions. Accounts at these institutions are insured by the Federal Deposit Insurance Corporation (“FDIC”) with basic deposit insurance coverage limits up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font> per owner. At March 31, 2018, the Company had cash balances of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">18.7</font> million which exceeded the FDIC insurance limit. The Company performs ongoing evaluations of these institutions to limit its concentration risk exposure.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2017Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
675679 | shares |
| CY2018Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6015307 | shares |
| CY2018Q1 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | USD |
| CY2018Q1 | us-gaap |
Cash
Cash
|
18700000 | USD |
| CY2018Q1 | cyrx |
Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
|
1580388 | shares |
| CY2018Q1 | cyrx |
Class Of Warrant Or Right Exercisable Terms
ClassOfWarrantOrRightExercisableTerms
|
The terms of the New Warrants included (i) an exercise price of $3.00 per share and (ii) an exercise period that expired concurrently with the expiration of the Offer at 5:00 p.m. (Eastern Time) on February 2, 2018 (the Expiration Date). In addition, the shares issuable upon exercise of the New Warrants (the New Warrant Shares) are subject to a 60-day lock-up period. | |
| CY2018Q1 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
99400 | USD |
| CY2017Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
26654 | USD |
| CY2018Q1 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
23073 | USD |
| CY2018Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2018Q1 | cyrx |
Warrants Exercised Intrinsic Value
WarrantsExercisedIntrinsicValue
|
10100000 | USD |
| CY2018Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><b>Note 2. Nature of the Business</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.38in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Cryoport is the premier provider of cryogenic logistics solutions to the life sciences industry through its purpose-built proprietary packaging, information technology and specialized cold chain logistics expertise. The Company provides leading edge logistics solutions for biologic materials, such as immunotherapies, stem cells, CAR-T cells and reproductive cells for clients worldwide. Leading global companies, such as FedEx, UPS and DHL have each separately selected Cryoport as the preferred cryogenic logistics provider for time- and temperature-sensitive biological material.  Cryoport actively supports points-of-care, contract research organizations, central laboratories, pharmaceutical and biotechnology companies, contract manufacturers and university researchers.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.38in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The Company is a Nevada corporation and its <font style="BACKGROUND-COLOR: transparent">common stock is traded on the NASDAQ Capital Market exchange under the ticker symbol “CYRX.”</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> |
